
Amneal Pharmaceuticals Investor Relations Material
Latest events

Q1 2025
Amneal Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Amneal Pharmaceuticals Inc
Access all reports
Amneal Pharmaceuticals, Inc. is a pharmaceutical company engaged in the development, manufacturing, and distribution of generic and specialty pharmaceutical products. The company offers a wide range of dosage forms, including oral solids, injectables, and topicals, addressing therapeutic areas such as central nervous system disorders, oncology, and cardiovascular conditions. The company is headquartered in Bridgewater, New Jersey, and its shares are listed on the NYSE.
Key slides for Amneal Pharmaceuticals Inc


Q3 2024
Amneal Pharmaceuticals Inc


Q1 2025
Amneal Pharmaceuticals Inc
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
AMRX
Country
🇺🇸 United States